JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

A3721 PHA-767491

Target: Cyclin-Dependent Kinases|MK2|Cdc7

Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive

insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
A5719 AT7519

Target: Cyclin-Dependent Kinases

Summary: Multi-CDK inhibitor
A5459 PHA-793887

1 Citation

Target: Cyclin-Dependent Kinases

Summary: Pan-Cdk inhibitor

insoluble in H2O; ≥18.05 mg/mL
A8316 PD 0332991 (Palbociclib) HCl

5 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,highly selective

≥14.48 mg/mL
A8616 A-674563

Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK

Summary: Akt1/PKA/CDK2 inhibitor,potent and selective

insoluble in EtOH; ≥23.8 mg/mL
A8642 R547

2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK1/2/4 inhibitor,ATP-competitive

Soluble in DMSO
A8326 AZD-5438

2 Citation

Target: Cyclin-Dependent Kinases

Summary: Potent CDK1/2/9 inhibitor

insoluble in H2O; ≥18.55 mg/mL
A1794 LY2835219

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor,potent and selective

≥30.15 mg/mL
A8385 BMS265246

Target: Cyclin-Dependent Kinases

Summary: CDK1/2 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥17.25 mg/mL
A3336 CVT-313

1 Citation

Target: Cyclin-Dependent Kinases

Summary: Cdk2 inhibitor

≥20 mg/mL